期刊文献+

Embelin通过上调死亡受体DR4/DR5mRNA表达增加HL-60细胞对TRAIL的敏感性 被引量:1

Embelin sensitizes HL- 60 cells to TRAIL by upregulation of DR4 /DR5 mRNA expression
下载PDF
导出
摘要 目的:探讨Embelin增加HL-60细胞对肿瘤坏死因子相关凋亡诱导配体(TRAIL)的敏感性及可能的作用机制。方法:TRAIL 1、5、10、50及100 ng/ml分别处理HL-60细胞6、12、24及48h,MTT法绘制细胞生长曲线;TRAIL 10 ng/ml±亚细胞毒浓度的Embelin处理HL-60细胞6、12、24及48h,Annexin V/PI复染流式细胞术检测细胞凋亡,Western blot检测24h时Caspase-3、8及9的表达;亚细胞毒浓度的Embelin处理HL-60细胞6、12、24及48h,实时荧光定量PCR检测DR4及DR5 mRNA的表达。结果:TRAIL对HL-60细胞具有增殖抑制作用。亚细胞毒浓度的Embelin联合10 ng/ml TRAIL作用于HL-60细胞时细胞凋亡率较单独应用TRAIL时增加,相应的Caspase-3、8及9的表达也随之增加。结论:亚细胞毒浓度的Embelin可以增加HL-60细胞对TRAIL的敏感性,其机制可能与上调DR4及DR5 mRNA表达并进而启动凋亡途径有关。 Objective:To investigate whether Embelin could sensitize HL-60 cells to TRAIL or not and explore the possible mechanism. Methods:HL- 60 cells were treated with TRAIL of 1,5,10,50 and 100 ng/ml for 6,12,24 and 48h seperatedly and proliferation curve was plotted by MTT assay. HL - 60 cells were treated with 10ng/ml TRAIL with or without Embelin of subtoxic concentration for 6,12,24 and 48h seperatedly,and cell apoptosis rate was detected by Annexin V/PI double staining and flow cytometry and Caspase - 3,8 and 9 at 24h by Western blot. HL - 60 cells were treated with Embelin of subtoxic concentration for 6,12,24 and 48h seperatedly,and DR4 and DR5 mR- NA were detected by real - time PCR. Results:TRAiL inhibited HL - 60 cells proliferation. TRAIL combined with Embelin of subtoxic concentration was more effective in inducing cell apoptosis than TRAIL alone and Caspase - 3,8 and 9 expression increase correspondingly. Conclusion: Embelin of subtoxic concentration could sensitize HL -60 cells to TRAIL. Upregulation of DR4 and DR5 mRNA and initiation of apoptosis pathway may contribute to the possi- ble mechanism.
出处 《现代肿瘤医学》 CAS 2014年第3期509-512,共4页 Journal of Modern Oncology
基金 辽宁省科学技术厅资助项目(编号:2010225032)
关键词 TRAIL 死亡受体 EMBELIN HL-60 凋亡 TRAIL death receptor Embelin HL - 60 apoptosis
  • 相关文献

参考文献10

  • 1Hu R,Zhu K,Li Y,et al.Embelin induces apoptosis through down-regulation of XIAP in human leukemia cells[J].Med Oncol,2011,28(4):1584-1588.
  • 2胡荣,吴斌,张国君,王洪涛,朱珂,杨威,刘卓刚.Embelin对HL-60细胞增殖、分化和凋亡的影响[J].中华血液学杂志,2010,31(7):442-445. 被引量:4
  • 3胡荣,杨莹,李佳,苗苗,朱珂,张继红,廖爱军,杨威,刘卓刚.Embelin对HL-60细胞MMP-9 mRNA、NF-κB及VEGF表达的影响[J].现代肿瘤医学,2012,20(6):1103-1105. 被引量:2
  • 4Alenzi FQ,Lotfy M,Wyse R.Swords of cell death:caspase activation and regulation[J].Asian Pac J Cancer Prev,2010,11(2):271-280.
  • 5Rushworth SA,Micheau O.Molecular crosstalk between TRAIL and natural antioxidants in the treatment of cancer[J].Br J Pharmacol,2009,157(7):1186-1188.
  • 6Lee YS,Lee DG,Lee JY,et al.A formulated red ginseng extract upregulates CHOP and increases TRAIL-mediated cytotoxicity in human hepatocellular carcinoma cells[J].Int J Oncol,2013,43(2):591-599.
  • 7Lirdprapamongkol K,Sakurai H,Abdelhamed S,et al.Chrysin overcomes TRAIL resistance of cancer cells through Mcl-1 downregulation by inhibiting STAT3 phosphorylation[J].Int J Oncol,2013,43(1):329-337.
  • 8Jane EP,Premkumar DR,Pollack IF.Bortezomib sensitizes malignant human glioma cells to TRAIL,mediated by inhibition of the NF-{kappa}B signaling pathway[J].Mol Cancer Ther,2011,10(1):198-208.
  • 9Ahn KS,Sethi G,Aggarwal BB.Embelin,an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein,blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products[J].Mol Pharmacol,2007,71(1):209-219.
  • 10Park SY,Lim SL,Jang HJ,et al.Embelin induces apoptosis in human glioma cells through inactivating NF-κB[J].J Pharmacol Sci,2013,121(3):192-199.

二级参考文献11

  • 1岳保红,张秋堂,秦东春,孙玲,王清霞,刘帅,张钦宪.K562和HL60细胞分化抗原的表达[J].郑州大学学报(医学版),2006,41(3):467-470. 被引量:5
  • 2Joshi R, Kamat JP,Mukherjee T. Free radical scavenging reactions and antioxidant activity of embelin: biochemical and pulse radinlyt- ic studies [ J ]. Chem Biol Interact, 2007,167 ( 2 ) : 125 - 134.
  • 3Ahn KS, Sethi G, Aggarwal BB. Embelin, an inhibitor of X chro- mosome - linked inhibitor - of - apoptosis protein, blocks nuclear factor - kappaB ( NF - kappaB) signaling pathway leading to sup- pression of NF - kappaB - regulated antiapoptotic and metastatic gene products[ J ]. Mol Pharmacoi ,2007,71 ( 1 ) :209 - 219.
  • 4ttu R, Zhu K, Li Y, el al. Embelin induces apoptosis throug} down- regulation f XIAP in human leukemia cells[ J]. Med On- col,2011,28(4) :1584 - 1588.
  • 5Nikolovska- Coleska Z, Xu L, Hu Z,et al. l)iscove of embelin as a cell - permeable, small - molecular weight inhibitor of XlAP lhrough structure - based computational screening of a Imditional herbal medicine three - dimensional structure database[ J ]. J Med Chem,2004,47 ( 10 ) :2430 - 2440.
  • 6Demchenko YN, Kuehl WM. A critical role for the NFKB pathway in multiple myeloma[ J ]. Oncotargc1,2010,1 ( 1 ) :59 -68.
  • 7Casabonne D, Reina O, Benavente Y, el al. Single nuelcotide pnlymorphisms of matrix metalloproteinase 9 (MMP9) aml tumor protein 73 (TP73) interaet with Epstein - Ban" virus in ehronie lymphoeytie leukemia: results front the European ease- control study EpiLymph[J]. Haematologica ,2011,96( 2 ) :323 - 327.
  • 8Russo I,A, Peano B J, Trivedi SP,et al. Regulated expression of matrix metalloproteinases, inflammatory mediators, and cndometri- al matrix remodeling by 17beta- estradiol in the immature rat ute- rus[ J ]. Reprod Biol Endocrino1,2009.7 : 124.
  • 9Knlizinga RC, de Jonge H J, Kampen KR,et al. Vas(.ular endothe- lial growth factr a isoform mRNA exprssion in pediatri acute mv- eloid leukemia [J]. Pedialr Blood Cancer, 2011 , 56 ( 2 ) : 294 - 297.
  • 10Shanafelt T, Zent (', Byrd J, el al. Phase 11 trials of" single - agent anti - VEGF therapy fir patients with chronic lymphocytic leukemia [ J ]. l,euk Lymphoma,2010,51 ( 12 ) :2222 - 2229.

共引文献4

同被引文献12

  • 1马远方,张军,赵粤萍,杨东亮,陈有海.肿瘤细胞对TRAIL敏感性与其表面DR5表达水平的相关性研究[J].中华肿瘤杂志,2004,26(9):528-530. 被引量:32
  • 2RUOSLAHTI E. The RGD story: a personal account[ J]. Matrix Biol, 2003, 22 (6) : 459 - 465.
  • 3RAJOTTE D, ARAP W, HAGEDORN M, et al. Molecular het- erogeneity of the vascular endothelium revealed by in vivo phage display[ J]. J Clin Invest, 1998, 102(2) :430 -437.
  • 4WILEY SR, SCHOOLEY K, SMOLAK PJ, et al. Identification and characterization of a new member of the TNF family induces apoptosis[ J]. Immunity, 1995, 3 (6) :673 - 682.
  • 5PITTI RM, MARSTERS SA, RUPPERT S, et al. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family [ J]. J Bio Chem, 1996, 271 (22) : 12687 - 12690.
  • 6GURA T. How TRAIL kills cancer cells, but not normal cells [J]. Science, 1997, 277(5327) : 768.
  • 7KIM Y, SEOL DW. TRAIL, a mighty apoptosis inducer[J].Mol Cells, 2003, 15(3) : 283 -293.
  • 8华子春,曹林.一种肿瘤坏死因子相关凋亡诱导配体变体及其应用:中国,200710133862.1[P].2008-04-09.
  • 9AN WF, TOLLIDAY N. Cell-based assays for high-throughput screening[J]. Mol Biotechnol, 2010, 45(2) :180 - 186.
  • 10王雪平,罗玉贤,马亮亮,顾福杭,赫建平,陈娟.TRAIL受体DR4、DR5、DcR1在结肠癌中的表达及意义[J].河北医药,2011,33(14):2090-2091. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部